AI’s impact on the life sciences industry and drug development

Tuesday, November 19, 2024

DLA Piper hosted a webinar that explored AI’s impact on drug development and the life sciences industry.

Partners Susan Krumplitsch, Ellen Scordino, and Danny Tobey discussed:

• Challenges and opportunities in patenting AI-related inventions
• AI’s role in disease identification and diagnosis, drug discovery, personalized medicine, and clinical trials
• Intellectual property protections when AI is part of your development story

CLE credit was offered for this event. 

For more information
Please contact Ryan King.